A R T I C L E S
Felicetti and Cane
obtained from Fluka. (R)-(+)-germacrene A was prepared by incubation
of FPP (1) with the W308F mutant of pentalenene synthase (plasmid
pMSO4), as previously described.20 All other reagents and buffer
components used for protein purification and enzyme assay were of
the highest quality commercially available.
expression, as judged by SDS-PAGE, was then used for kinetic analysis
and preparative scale incubations.
P. roqueforti Aristolochene Synthase. Individual strains of E. coli
BL21(DE3) harboring mutant plasmids for P. roqueforti aristolochene
synthase were each grown overnight in 8 mL of LB medium containing
100 µg/mL ampicillin at 37 °C. The resulting culture (8 mL) was used
to inoculate pre-warmed LB medium (800 mL, 100 µg/mL ampicillin)
and the cells were grown at 30 °C to an OD600 of 1.0. Protein expression
was then induced with 1 mM IPTG. Following 6 h of incubation at 30
°C (250 rpm) the cells were harvested by centrifugation (6000 × g, 25
min, 4 °C). The cell pellet was resuspended in 50 mL of cell lysis
buffer (5 mM EDTA, 5 mM â-mercaptoethanol, 20 mM Tris pH 7.5)
and recentrifuged (6000 × g, 25 min, 4 °C) to remove any remaining
LB medium. The cells were then suspended in 50 mL of lysis buffer
and broken by sonication (three cycles of 10 min each, 30% power
range, 50% duty cycle) in an ice water bath. The pellet was then
resuspended in the same buffer and recentrifuged to remove traces of
soluble protein. The subsequent solubilization and purification of the
mutant proteins were performed as previously described for wild-type
P. roqueforti aristolochene synthase.11 Fractions containing pure enzyme
were identified by SDS-PAGE, combined, and concentrated to a final
volume of 2.5 mL using an Amicon ultrafiltration apparatus equipped
with a YM-30 filter. The final enzyme purity was greater than 90% as
judged by SDS-PAGE analysis. The concentrated protein was dialyzed
against Buffer T (20 mM Tris pH 7.5, 15% glycerol, 5 mM MgCl2, 5
mM â-mercaptoethanol) using a PD-10 desalting column (SephadexTM
G-25, Pharmacia) and the protein was stored at -80 °C.
A. terreus Aristolochene Synthase. Individual strains of E. coli
BL21(DE3)pLysS/pET11rASa and derivatives harboring the wild-type
and mutant plasmids of A. terreus aristolochene synthase were grown
overnight in 10 mL of LB media containing 100 µg/mL carbenicillin
at 37 °C. The overnight seed culture was used to inoculate 1 L of pre-
warmed (30 °C) LB-carbenicillin (100 µg/mL) and the cells were grown
until the OD600 reached 1.0. Protein expression was then induced with
1 mM IPTG. After 6 h of incubation the cells were harvested by
centrifugation (6000 × g, 30 min, 4 °C). The pellet was then
re-suspended in 50 mL of MEG buffer (20 mM Mes pH 6.5, 2 mM
EDTA, 10% glycerol, 5 mM 2-mercaptoethanol) and recentrifuged
(6000 × g, 30 min, 4 °C) to remove any remaining LB medium. The
cells were resuspended in 50 mL of MEG buffer and broken by
sonication (three cycles of 10 min each, 50% duty cycle and 30% power
range) in an ice water bath. The crude cell lysate was centrifuged
(17 000 × g, 30 min, 4 °C) and the supernatant, containing soluble
aristolochene synthase was collected. The subsequent purification of
the A. terreus aristolochene synthase was based on the previously
published procedure for the wild-type protein.5 Fractions containing
pure enzyme were located by SDS-PAGE and combined. The solution
was concentrated to 0.5 mL using an Amicon ultrafiltration apparatus
equipped with an YM-10 filter, the buffer was changed to protein
storage buffer (20 mM Hepes pH 8.0, 5 mM MgCl2 and 10% glycerol)
using a PD-10 desalting column and the protein was stored at -80 °C.
Using the above expression procedure, the A. terreus mutant AT-N219D
was obtained exclusively as inclusion bodies despite the use of lower
induction temperatures, lower IPTG concentrations and longer induction
time. Cells were therefore suspended in 50 mL of cell lysis buffer (MEG
buffer) and sonicated. The lysate was centrifuged (6000 × g for 30
min at 4 °C) and the pellet, containing the insoluble inclusion bodies,
was resuspended in 200 mL of MEG buffer. The inclusion bodies were
solubilized and the protein was purified following the same method
used for the P. roqueforti enzymes11 except that MEG buffer was
utilized for the solubilization and purification. The fractions containing
the protein were combined and concentrated using a centriprep YM-
30 centrifugal filter to a final volume of 2.5 mL, the buffer was changed
to protein storage buffer using a PD-10 desalting column, and the
protein was stored at -80 °C.
General Methods. Standard recombinant DNA and protein ma-
nipulations were carried out according to published procedures.30 PCR
and restriction digestions were run in a MiniCycler thermocycler from
MJ Research, equipped with a hot-bonnet. Aristolochene synthase
mutants were generated with the QuikChange site-directed mutagenesis
kit using the manufacturer’s protocols. DNA sequencing was performed
by the HHMI Biopolymer/Keck Foundation Biotechnology Resource
Laboratory at the Yale University School of Medicine, New Haven
(CT), using the dideoxy dye terminator method and automated
fluorescence sequencing. Protein concentrations were determined by
the Bradford method using commercial reagents (Bio-Rad) and bovine
serum albumin (Sigma) as a calibration standard.31 Liquid scintillation
was performed on a Beckman Model LS-6500 liquid scintillation
counter using Packard OmniFluor scintillation cocktail. Analysis of
DNA and protein sequences as well as PCR primer design utilized the
suite of programs in the GCG Sequence Analysis Package, version 10.0
(Unix), from Accelrys. The Insight II software package (Accelrys) was
used to visualize and manipulate Protein Data Bank (PDB) files
corresponding to the crystal structures of aristolochene synthase
(accession code 1DI1) and that of aristolochene synthase com-
plexed with FPP (1) (accession code 1F1P). A structural model of
the A. terreus aristolochene synthase (Genbank accession number
AF198360) was generated through the Swiss-Model website (http://
swissmodel.expasy.org) using the structure of chain B of the P.
roqueforti enzyme (1DI1B) as a template.32 GC-MS analysis of
enzymatic reaction products was performed using a HP-GCD series II
GC-MS system equipped with either an Optima 1701 capillary GC
column (14% cyanopropyl-phenyl/86% dimethyl polysiloxane) or a
chiral capillary GC column (FS-hydrodex-â-6TBDM), both purchased
from Macherey-Nagel. Both columns were 30 m in length with an
internal diameter of 0.25 mm and 0.25 µm phase thickness.
Aristolochene Synthase Mutants. Aristolochene synthase mutants
were prepared by PCR mutagenesis with the QuikChange site-directed
mutagenesis kit according to the manufacturer’s protocols, using as
template plasmid DNA from pZW04, harboring the P. roqueoforti
aristolochene synthase10 or pET11rASa, harboring the A. terreus
aristolochene synthase.5 For the P. roqueforti double mutant, S248A/
E252Q, the E252Q mutation was introduced using the plasmid pZWO4/
S248A as the template for PCR. Plasmid pZWO4 was extracted from
an overnight culture of E. coli XL1Blue/pZWO4 grown in Luria Bertani
(LB) ampicillin (100 µg/mL) medium, and purified using the Miniprep
plasmid purification kit. For each mutation the forward and the reverse
mutagenenic primers consisted of two complementary oligonucleotides
(25-45 nt) containing the desired mutation flanked by unmodified
nucleotide sequences. Each primer was designed and purified according
to the vendor’s recommendations. Mutant plasmids isolated from
overnight cultures of three separate colonies were purified by plasmid
miniprep and the incorporation of the desired mutation was verified
by DNA sequencing. One of the sequenced plasmids was then utilized
to transform competent cells of the expression host strain E. coli
BL21(DE3). From the resultant transformants, three single colonies
were chosen and assayed by SDS-PAGE for aristolochene synthase
production after IPTG induction. All of the colonies were found to
overexpress the enzyme. The colony giving rise to the highest level of
(30) Sambrook, J.; Fritsch, E. F.; Maniatis, T. Molecular Cloning: a Laboratory
Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY,
1989. Current Protocols in Molecular Biology, CD-ROM; Wiley: New
York, 1999.
(31) Bradford, M. Anal. Biochem. 1976, 72, 248-254.
(32) Schwede, T.; Kopp, J.; Guex, N.; Peitsch, M. C. Nucleic Acids Res. 2003,
31, 3381-3385. Guex, N.; Peitsch, M. C. Electrophoresis 1997, 18, 2714-
2723. Peitsch, M. C. Bio/Technology 1995, 13, 658-660.
9
7220 J. AM. CHEM. SOC. VOL. 126, NO. 23, 2004